{"id":"ethynyl-estradiol-and-drospirenone","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Breast tenderness"},{"rate":"5-10%","effect":"Mood changes"},{"rate":"5-10%","effect":"Vaginal bleeding irregularities"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ethynyl estradiol is a synthetic estrogen that inhibits ovulation by suppressing the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn reduces the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Drospirenone, a progestin, has anti-androgenic and anti-mineralocorticoid effects, which contribute to its contraceptive efficacy.","oneSentence":"Ethynyl estradiol and drospirenone work by inhibiting ovulation and thickening cervical mucus to prevent sperm penetration.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:52:14.246Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"}]},"trialDetails":[{"nctId":"NCT07127458","phase":"NA","title":"Anxiety and Depression in Adolescent PCOS","status":"COMPLETED","sponsor":"Ege University","startDate":"2025-08-17","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":42},{"nctId":"NCT07235774","phase":"PHASE1","title":"A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants","status":"RECRUITING","sponsor":"Institut de Recherches Internationales Servier (I.R.I.S.)","startDate":"2025-11-05","conditions":"Healthy Adult Female Participants","enrollment":28},{"nctId":"NCT07074327","phase":"PHASE1","title":"Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2025-07-11","conditions":"Autosomal Dominant Polycystic Kidney Disease (ADPKD)","enrollment":74},{"nctId":"NCT07229209","phase":"NA","title":"Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-05","conditions":"Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar","enrollment":166},{"nctId":"NCT07340190","phase":"PHASE1","title":"A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Advanced Malignancies","enrollment":24},{"nctId":"NCT07318337","phase":"NA","title":"Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS","status":"COMPLETED","sponsor":"Mst.Sumyara Khatun","startDate":"2024-07-01","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":60},{"nctId":"NCT07242131","phase":"NA","title":"Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS","status":"RECRUITING","sponsor":"Ege University","startDate":"2025-12-01","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":150},{"nctId":"NCT03819140","phase":"PHASE4","title":"Continuous Versus Cyclical OCP Use in PCOS","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-04-01","conditions":"Polycystic Ovary Syndrome","enrollment":51},{"nctId":"NCT07181343","phase":"PHASE1","title":"A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)","status":"COMPLETED","sponsor":"Hansoh BioMedical R&D Company","startDate":"2025-05-28","conditions":"Psoriasis (PsO)","enrollment":18},{"nctId":"NCT06186271","phase":"","title":"International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)","status":"RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2025-04-24","conditions":"Contraception","enrollment":68100},{"nctId":"NCT06028555","phase":"","title":"International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study","status":"RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2023-06-28","conditions":"Contraception, Birth Control","enrollment":101000},{"nctId":"NCT07061093","phase":"","title":"Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational Study","status":"RECRUITING","sponsor":"Ospedale Policlinico San Martino","startDate":"2023-10-10","conditions":"Cardiovascular System Diseases (&Amp; [Cardiac])","enrollment":96},{"nctId":"NCT06820307","phase":"PHASE1","title":"Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2025-02-25","conditions":"Pain","enrollment":50},{"nctId":"NCT06396221","phase":"NA","title":"\"Quick-starting\" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-05-01","conditions":"Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile","enrollment":36},{"nctId":"NCT05706753","phase":"PHASE1","title":"A Study of Milvexian in Healthy Adult Females","status":"COMPLETED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2023-01-25","conditions":"Healthy Female","enrollment":20},{"nctId":"NCT02636972","phase":"","title":"The Progression From Dysmenorrhoea to Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University of Adelaide","startDate":"2014-11","conditions":"Dysmenorrhoea, Pelvic Pain, Chronic Pain","enrollment":56},{"nctId":"NCT05934942","phase":"PHASE1","title":"A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2023-09-08","conditions":"Healthy","enrollment":29},{"nctId":"NCT06608186","phase":"PHASE1, PHASE2","title":"Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!","status":"COMPLETED","sponsor":"Ahmed Saad","startDate":"2024-10-01","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":50},{"nctId":"NCT05098574","phase":"PHASE2","title":"Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder","status":"COMPLETED","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2023-02-03","conditions":"Premenstrual Dysphoric Disorder, Bipolar Disorder","enrollment":17},{"nctId":"NCT06250205","phase":"PHASE1","title":"Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib","status":"COMPLETED","sponsor":"NewAmsterdam Pharma","startDate":"2024-02-05","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT06577974","phase":"NA","title":"Role of Medical Treatment in Endometriosis Patients Undergoing ICSI","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Endometriosis","enrollment":129},{"nctId":"NCT06039826","phase":"PHASE1","title":"A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-09-12","conditions":"Overweight","enrollment":46},{"nctId":"NCT01277211","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-09-19","conditions":"Contraception","enrollment":983},{"nctId":"NCT05872425","phase":"NA","title":"Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2023-02-01","conditions":"PCOS","enrollment":120},{"nctId":"NCT06324851","phase":"PHASE4","title":"The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":150},{"nctId":"NCT06233071","phase":"PHASE1","title":"Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®","status":"RECRUITING","sponsor":"Bio-innova Co., Ltd","startDate":"2024-02-13","conditions":"Healthy Subjects","enrollment":32},{"nctId":"NCT06233058","phase":"PHASE1","title":"Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®","status":"UNKNOWN","sponsor":"Bio-innova Co., Ltd","startDate":"2024-03-05","conditions":"Healthy Subjects","enrollment":32},{"nctId":"NCT05985590","phase":"PHASE1","title":"A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2023-08-18","conditions":"Healthy Volunteers","enrollment":37},{"nctId":"NCT06083935","phase":"PHASE4","title":"Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-11-01","conditions":"Poly Cystic Ovary Syndrome","enrollment":120},{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT03091595","phase":"PHASE2","title":"E4/DRSP Ovarian Function Inhibition Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2017-02-07","conditions":"Prevention of Pregnancy","enrollment":82},{"nctId":"NCT04984070","phase":"NA","title":"Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2021-01-01","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Depression, Anxiety","enrollment":100},{"nctId":"NCT04278755","phase":"PHASE2","title":"Binge Eating & Birth Control","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-09-24","conditions":"Bulimia Nervosa, Binge Eating, Eating Disorders","enrollment":8},{"nctId":"NCT04831151","phase":"NA","title":"The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics","status":"UNKNOWN","sponsor":"Inonu University","startDate":"2021-03-01","conditions":"Polycystic Ovary Syndrome","enrollment":42},{"nctId":"NCT00413062","phase":"PHASE3","title":"Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06","conditions":"Contraception","enrollment":2281},{"nctId":"NCT00511433","phase":"PHASE3","title":"Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":48},{"nctId":"NCT00511199","phase":"PHASE3","title":"Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05-01","conditions":"Contraception","enrollment":2152},{"nctId":"NCT05156879","phase":"PHASE4","title":"Aspirin for the Management of Endometriosis-associated Pelvic Pain","status":"UNKNOWN","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2021-12-23","conditions":"Pelvic Pain","enrollment":220},{"nctId":"NCT01291004","phase":"PHASE1","title":"A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2011-01-31","conditions":"Follicle Development, Ovarian Follicle, Follicle Count","enrollment":206},{"nctId":"NCT05135013","phase":"","title":"The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study","status":"UNKNOWN","sponsor":"NewGiza University","startDate":"2021-11-16","conditions":"Observational Study","enrollment":200},{"nctId":"NCT04256200","phase":"PHASE2, PHASE3","title":"Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2017-02-07","conditions":"Endometriosis","enrollment":100},{"nctId":"NCT03890341","phase":"PHASE1","title":"Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440","status":"WITHDRAWN","sponsor":"Janssen Research & Development, LLC","startDate":"2021-06-01","conditions":"Healthy","enrollment":""},{"nctId":"NCT01805817","phase":"PHASE4","title":"Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality","status":"WITHDRAWN","sponsor":"Istanbul Training and Research Hospital","startDate":"2012-12","conditions":"Contraceptive Methods Comparison","enrollment":""},{"nctId":"NCT01266408","phase":"","title":"INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2010-11-22","conditions":"Contraception","enrollment":82921},{"nctId":"NCT01519401","phase":"NA","title":"Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2010-02","conditions":"Polycystic Ovary Syndrome, Estro-progestin Drugs","enrollment":50},{"nctId":"NCT03353857","phase":"PHASE1","title":"Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-11-29","conditions":"Biological Availability","enrollment":68},{"nctId":"NCT03843736","phase":"PHASE3","title":"The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-02-21","conditions":"Polycystic Ovary Syndrome","enrollment":200},{"nctId":"NCT03857230","phase":"PHASE1","title":"The Safety and Pharmacokinetics of Primapur and Gonal-f","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2015-10-29","conditions":"Area Under Curve, Pharmacokinetics, Absorption","enrollment":28},{"nctId":"NCT02710708","phase":"PHASE4","title":"YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-05-27","conditions":"Contraception","enrollment":1921},{"nctId":"NCT00745901","phase":"PHASE4","title":"Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2008-05","conditions":"Contraception","enrollment":355},{"nctId":"NCT01195974","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.","status":"TERMINATED","sponsor":"ViiV Healthcare","startDate":"2010-09-14","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":13},{"nctId":"NCT02957630","phase":"PHASE1, PHASE2","title":"\"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study\"","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-09","conditions":"Contraception, Liver Metabolism, Hemostasis Parameter","enrollment":101},{"nctId":"NCT00640224","phase":"PHASE4","title":"Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study","status":"COMPLETED","sponsor":"Silva Arslanian","startDate":"2005-03","conditions":"Polycystic Ovary Syndrome","enrollment":65},{"nctId":"NCT01254292","phase":"PHASE3","title":"LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-01-06","conditions":"Contraception","enrollment":567},{"nctId":"NCT03111511","phase":"PHASE1","title":"A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)","status":"COMPLETED","sponsor":"Janssen Sciences Ireland UC","startDate":"2017-03-27","conditions":"Healthy","enrollment":18},{"nctId":"NCT03126097","phase":"PHASE1","title":"A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-04-13","conditions":"Healthy","enrollment":18},{"nctId":"NCT00089414","phase":"PHASE2","title":"Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives","status":"TERMINATED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2004-07","conditions":"Premenstrual Syndrome, PMS, Premenstrual Dysphoric Disorder","enrollment":5},{"nctId":"NCT02841202","phase":"PHASE4","title":"The Effect of Oral Contraceptive Pills On Eyes","status":"COMPLETED","sponsor":"Kayseri Education and Research Hospital","startDate":"2014-01","conditions":"Adverse Effect of Oral Contraceptives, Subsequent Encounter","enrollment":40},{"nctId":"NCT03124524","phase":"PHASE4","title":"Treatment Choice in Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Adana Numune Training and Research Hospital","startDate":"2015-01-15","conditions":"Primary Dysmenorrhea","enrollment":99},{"nctId":"NCT01360996","phase":"PHASE4","title":"Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism","status":"COMPLETED","sponsor":"Woman's","startDate":"2011-08","conditions":"Polycystic Ovary Syndrome","enrollment":64},{"nctId":"NCT00633360","phase":"NA","title":"The Oral Contraceptive Pill for Premenstrual Worsening of Depression","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-02","conditions":"Premenstrual Syndrome, Depression","enrollment":32},{"nctId":"NCT03037944","phase":"EARLY_PHASE1","title":"Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-03-01","conditions":"Adenomyosis","enrollment":32},{"nctId":"NCT00511797","phase":"PHASE2, PHASE3","title":"SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-07","conditions":"Dysmenorrhea","enrollment":249},{"nctId":"NCT02885454","phase":"PHASE1","title":"To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-08","conditions":"Healthy","enrollment":24},{"nctId":"NCT02488538","phase":"PHASE3","title":"Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-07","conditions":"Premenstrual Syndrome","enrollment":300},{"nctId":"NCT00927095","phase":"PHASE4","title":"Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-07","conditions":"Premenstrual Dysphoric Disorder","enrollment":67},{"nctId":"NCT02855294","phase":"PHASE4","title":"The Effect of Oral Contraceptives on Women Balance","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-01","conditions":"Joint Stabilioty","enrollment":100},{"nctId":"NCT01109979","phase":"PHASE4","title":"Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2009-12","conditions":"Cardiovascular Diseases","enrollment":24},{"nctId":"NCT02562053","phase":"PHASE3","title":"Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-10","conditions":"Premenstrual Syndrome","enrollment":300},{"nctId":"NCT02757469","phase":"NA","title":"Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure","status":"UNKNOWN","sponsor":"Navy General Hospital, Beijing","startDate":"2016-05","conditions":"Primary Ovarian Insufficiency, Menopause, Premature","enrollment":20},{"nctId":"NCT01902264","phase":"PHASE3","title":"Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-08","conditions":"Contraception","enrollment":34},{"nctId":"NCT02681536","phase":"NA","title":"Miniflare Versus Long Protocol in Poor Responders","status":"UNKNOWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2016-02","conditions":"Infertility","enrollment":200},{"nctId":"NCT01697111","phase":"PHASE3","title":"Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-10","conditions":"Endometriosis","enrollment":312},{"nctId":"NCT02617537","phase":"PHASE3","title":"To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea","status":"WITHDRAWN","sponsor":"Bayer","startDate":"2016-01","conditions":"Dysmenorrhea","enrollment":""},{"nctId":"NCT00923572","phase":"","title":"Yasmin Post Marketing Surveillance","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-12","conditions":"Contraception","enrollment":777},{"nctId":"NCT01892904","phase":"PHASE3","title":"Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-07","conditions":"Dysmenorrhea","enrollment":216},{"nctId":"NCT00818519","phase":"PHASE3","title":"GA YAZ ACNE in China Phase III","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Acne Vulgaris","enrollment":179},{"nctId":"NCT02089620","phase":"PHASE3","title":"Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2014-05","conditions":"Premenstrual Syndrome","enrollment":210},{"nctId":"NCT00283816","phase":"PHASE3","title":"Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2006-01","conditions":"Polycystic Ovary Syndrome","enrollment":36},{"nctId":"NCT00714233","phase":"PHASE3","title":"Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2002-08","conditions":"Polycystic Ovary Syndrome","enrollment":43},{"nctId":"NCT01608698","phase":"PHASE4","title":"Comparison of Body Weight Change During Contraception With Belara and Yasmin","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2012-06","conditions":"Body Weight Changes","enrollment":100},{"nctId":"NCT00998257","phase":"","title":"Regulatory Post Marketing Surveillance Study on YAZ","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-07","conditions":"Contraception, Premenstrual Syndrome, Acne","enrollment":770},{"nctId":"NCT02342093","phase":"PHASE4","title":"Contraceptives Containing Drospirenone and Blood Pressure","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2011-01","conditions":"Blood Pressure, Contraception","enrollment":44},{"nctId":"NCT00185484","phase":"PHASE3","title":"Efficacy and Safety Oral Contraceptive Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03","conditions":"Contraception","enrollment":1113},{"nctId":"NCT00651846","phase":"PHASE4","title":"Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Healthy","enrollment":43},{"nctId":"NCT00656981","phase":"PHASE3","title":"Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-01","conditions":"Acne Vulgaris","enrollment":541},{"nctId":"NCT00651469","phase":"PHASE3","title":"Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-01","conditions":"Acne Vulgaris","enrollment":534},{"nctId":"NCT02027337","phase":"PHASE4","title":"Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants","status":"UNKNOWN","sponsor":"Tyumen State Medical Academy","startDate":"2013-12","conditions":"Polycystic Ovarian Syndrome, Hyperandrogenism, Menstrual Irregularities","enrollment":200},{"nctId":"NCT00266032","phase":"PHASE3","title":"Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-12","conditions":"Contraception","enrollment":1166},{"nctId":"NCT00569244","phase":"PHASE3","title":"SH T00186 in the Treatment of Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-12","conditions":"Primary Dysmenorrhea","enrollment":223},{"nctId":"NCT01257984","phase":"PHASE3","title":"Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-12","conditions":"Contraception","enrollment":508},{"nctId":"NCT01076582","phase":"PHASE3","title":"Comparative Trial in Hormone Withdrawal Associated Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-04","conditions":"Oral Contraceptive","enrollment":592},{"nctId":"NCT00673686","phase":"PHASE2","title":"Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-05","conditions":"Contraceptives, Oral","enrollment":105},{"nctId":"NCT02237131","phase":"PHASE4","title":"Continuous Versus Cyclic Oral Contraceptives for Endometriosis","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-04","conditions":"Dysmenorrhea, Pelvic Pain, Dyspareunia","enrollment":50},{"nctId":"NCT00988910","phase":"","title":"Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-01","conditions":"Contraception","enrollment":632},{"nctId":"NCT00442689","phase":"NA","title":"Metabolic Syndrome in PCOS: Precursors and Interventions","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2006-07","conditions":"Polycystic Ovary Syndrome, Metabolic Syndrome","enrollment":97},{"nctId":"NCT00468481","phase":"PHASE3","title":"Efficacy and Safety Study for an Oral Contraceptive Containing Folate","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-04","conditions":"Neural Tube Defects, Contraception, Oral Contraceptives (OC)","enrollment":385},{"nctId":"NCT00567164","phase":"PHASE3","title":"Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-10","conditions":"Contraception, Ovulation Inhibition, Contraceptives, Oral","enrollment":1887},{"nctId":"NCT00722800","phase":"PHASE2","title":"A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2008-10","conditions":"Hidradenitis Suppurativa","enrollment":4},{"nctId":"NCT00367276","phase":"PHASE3","title":"Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-12","conditions":"Healthy","enrollment":221}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":467,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Ethynyl estradiol and Drospirenone","genericName":"Ethynyl estradiol and Drospirenone","companyName":"Ospedale Policlinico San Martino","companyId":"ospedale-policlinico-san-martino","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethynyl estradiol and drospirenone work by inhibiting ovulation and thickening cervical mucus to prevent sperm penetration. Used for Contraception.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}